SERPINE1 and Impaired glucose tolerance: High levels of plasminogen activator inhibitor-1 (PAI-1), a potent inhibitor of fibrinolysis, have been seen in patients with impaired glucose tolerance (IGT) (25), as well as insulin-resistance (26), and could play a role in the pathogenesis of psoriasis.